|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | |||||
| Net loss | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Nonmonetary Transaction, Gain (Loss) Recognized on Transfer | |||||
| Goodwill, Impairment Loss | |||||
| Other, net | |||||
| Increase (Decrease) in Operating Assets | |||||
| Accounts and other receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued liabilities, and other liabilities | |||||
| Reserve for veterinary invoices | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | |||||
| Purchases of investment securities | |||||
| Maturities and sales of investment securities | |||||
| Cash paid in business acquisition, net of cash acquired | |||||
| Purchases of property, equipment, and internal-use software | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | |||||
| Payments for Repurchase of Common Stock | |||||
| Proceeds from exercise of stock options | |||||
| Shares withheld to satisfy tax withholding | |||||
| Proceeds from debt financing, net of financing fees | |||||
| Repayment of debt financing | |||||
| Other | |||||
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance | |||||
| Supplemental Cash Flow Information | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Purchases of property, equipment, and internal-use software included in accounts payable and accrued liabilities | |||||
| Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | |||||
| Noncash or Part Noncash Acquisition, Description | |||||
Loading...